IPR filing up 64% in February compared with previous month
February was a busy month for PTAB petition filing, and also included a rare reversal of a split decision from the Board as well as the first set of final written decisions on biopharmaceutical IPRs
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: